Amylyx Pharmaceuticals Inc (AMLX)
5.715
+0.08
(+1.33%)
USD |
NASDAQ |
Nov 04, 16:00
5.715
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Price: 5.715 for Nov. 4, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 01, 2024 | 5.42 | 5.80 | 5.412 | 5.64 | 1.320M |
Oct 31, 2024 | 5.21 | 5.535 | 5.20 | 5.40 | 1.114M |
Oct 30, 2024 | 5.06 | 5.475 | 5.06 | 5.27 | 1.268M |
Oct 29, 2024 | 5.42 | 5.448 | 4.88 | 5.07 | 1.559M |
Oct 28, 2024 | 5.33 | 5.66 | 5.14 | 5.33 | 1.900M |
Oct 25, 2024 | 4.90 | 5.495 | 4.86 | 5.31 | 2.135M |
Oct 24, 2024 | 5.00 | 5.14 | 4.795 | 4.90 | 1.108M |
Oct 23, 2024 | 5.05 | 5.30 | 4.714 | 4.96 | 2.956M |
Oct 22, 2024 | 4.66 | 4.825 | 4.45 | 4.53 | 1.170M |
Oct 21, 2024 | 4.77 | 5.04 | 4.40 | 4.66 | 2.564M |
Oct 18, 2024 | 4.07 | 5.439 | 3.86 | 4.78 | 4.823M |
Oct 17, 2024 | 4.13 | 4.46 | 3.36 | 3.92 | 3.317M |
Oct 16, 2024 | 3.98 | 4.14 | 3.86 | 4.08 | 1.346M |
Oct 15, 2024 | 3.60 | 3.95 | 3.60 | 3.94 | 1.555M |
Oct 14, 2024 | 3.55 | 3.64 | 3.42 | 3.58 | 709468.0 |
Oct 11, 2024 | 3.47 | 3.63 | 3.44 | 3.55 | 1.069M |
Oct 10, 2024 | 3.36 | 3.47 | 3.28 | 3.46 | 883362.0 |
Oct 09, 2024 | 3.27 | 3.48 | 3.20 | 3.39 | 1.525M |
Oct 08, 2024 | 3.08 | 3.33 | 3.065 | 3.26 | 1.248M |
Oct 07, 2024 | 3.11 | 3.18 | 3.04 | 3.08 | 830032.0 |
Oct 04, 2024 | 2.94 | 3.16 | 2.94 | 3.12 | 743191.0 |
Oct 03, 2024 | 3.01 | 3.07 | 2.910 | 2.94 | 788751.0 |
Oct 02, 2024 | 3.05 | 3.065 | 2.93 | 3.03 | 739009.0 |
Oct 01, 2024 | 3.25 | 3.29 | 3.051 | 3.06 | 1.134M |
Sep 30, 2024 | 3.05 | 3.27 | 3.05 | 3.24 | 1.487M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.62
Minimum
Jun 18 2024
40.93
Maximum
Jan 27 2023
18.54
Average
19.12
Median
Price Benchmarks
PTC Therapeutics Inc | 40.41 |
NovaBay Pharmaceuticals Inc | 0.78 |
Palatin Technologies Inc | 1.20 |
iBio Inc | 2.66 |
Theriva Biologics Inc | 2.08 |
Price Related Metrics
PS Ratio | 1.316 |
PEG Ratio | -0.0239 |
Price to Book Value | 1.489 |
Earnings Yield | -42.87% |
Market Cap | 389.09M |
PEGY Ratio | -0.0239 |